Related Experiment Video
Updated: Jun 24, 2026
Quantitative Measurement of Intrathecally Synthesized Proteins in Mice
Published on: November 29, 2019
Calcitonin gene-related peptide concentration in cerebrospinal fluid and serum in horses affected by
Lisa Annabel Weber1, Hilke Oltmanns2, Ludovica Chiavaccini3
1Clinic for Horses, University of Veterinary Medicine Hannover, Foundation, Hannover, Germany.
Background:
Trigeminal-mediated headshaking (TMHS) in horses shares clinical features with human trigeminal neuralgia (HTN). Increased levels of the neuropeptide calcitonin gene-related peptide (CGRP) have been found in the blood and cerebrospinal fluid (CSF) of HTN patients. Inhibition of CGRP in humans has shown promise for pain relief. Data on CGRP in horses affected by TMHS are currently lacking but if quantifiable and validated, could assist in developing new diagnostic and more rational therapeutic approaches.
Objectives:
This study aimed to quantify and correlate CGRP concentrations in the serum and CSF of horses with TMHS; compare CSF CGRP levels across horses with various neurological, painful, inflammatory and chronic conditions; analyse serum CGRP concentrations before and after exercise-induced headshaking in affected horses versus healthy controls.
Study Design:
Case-control study using bio-banked samples and prospective before-after study.
Methods:
CGRP concentrations were measured in CSF and serum using a commercial ELISA kit across healthy controls (CONTROL, n = 5), TMHS-affected horses (n = 30), horses with cervical vertebral stenotic myelopathy (CVSM, n = 10) and horses with non-neurologic painful, inflammatory or chronic conditions (MIXED, n = 8).
Results:
Median (interquartile range [IQR]) serum CGRP concentration in TMHS horses was 14.9 pg/mL (11.3-19.0 pg/mL), while mean ± SD CGRP CSF concentration was 64.9 ± 6.3 pg/mL. No correlation was found between serum and CSF CGRP (Spearman's rho = -0.04, p = 0.88). CSF CGRP levels were significantly higher in CVSM (73.8 pg/mL; p = 0.011) and lower in MIXED (52.0 pg/mL; p = 0.001) compared to TMHS. Serum CGRP concentrations showed no significant difference between TMHS and CONTROL groups.
Main Limitations:
Small sample size, lack of CSF samples from healthy controls.
Conclusions:
Higher CSF CGRP levels in neurologic conditions may suggest shared underlying mechanisms such as nerve irritation or neuroinflammation. Further research is needed to elucidate CGRP's role in TMHS pathophysiology.
More Related Videos
08:39Ex Vivo Release of Calcitonin Gene-Related Peptide from the Trigeminovascular System in Rodents
Published on: May 16, 2022
07:14Detection and Quantification of Calcitonin Gene-Related Peptide CGRP in Human Plasma Using a Modified Enzyme-Linked Immunosorbent Assay
Published on: June 16, 2023
Related Concept Videos
01:17Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
00:51Synthesis and Functions of Calcitonin
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
01:24Graves Disease II: Pathophysiology